Search results
New COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 8 hours agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
A promising vaccine approach to induce longer-lasting protective immunity against COVID-19
Medical Xpress· 8 hours agoIn an ongoing, four-year collaboration, the team leveraged a novel vaccine platform to fuse the receptor-binding domain (RBD) from the spike protein of the SARS-CoV ...
Researchers take step toward development of universal COVID-19 antibodies
KTBS Shreveport· 5 days ago"This antibody worked against the original SARS-CoV-2 strain, Omicron and SARS-CoV< ...
Analyzing The Emergence Of Covid Variant KP.2 And Its Potential Impact
Forbes· 5 days agoLike influenza, an easily transmissible respiratory virus, SARS-CoV-2 mutates to evade the immune...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 2 days agoThe current predominant strain of COVID-19 should be a key consideration during the upcoming meeting...
The Push to Get More People Into Long COVID Studies
Medscape· 1 day agoWhen Ezra Spier was diagnosed with long COVID in late 2022, his main symptom, postexertional malaise, caused fatigue so severe that it forced him to quit...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 22 hours agoGHENT, Belgium, June 04, 2024 (GLOBE NEWSWIRE) -- ExeVir Bio, a biotech company developing robust heavy chain-only antibody therapies for broad protection against infectious ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoInvivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced general alignment with the U.S. Food and Drug ...
Fauci testifies about COVID pandemic response at heated House hearing
CBS News· 2 days agoDr. Anthony Fauci testified on Monday before a Republican-led House panel investigating the origins...
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 5 days agoInvivyd Inc. (NASDAQ: IVVD), a biopharmaceutical company, has announced an agreement with the U.S....